StonvexLoading…
StonvexStonvexStonvexCore line items from CYRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $49.17M | $47.80M | $176.18M | $130.73M | $86.49M |
Operating Income | Not available | $-9.61M | $-36.81M | $-26.77M | $-16.84M |
Net Income | Not available | $-10.54M | $78.30M | $89.94M | $93.20M |
EPS (Diluted) | $-0.20 | $-0.25 | $1.40 | $1.68 | $1.78 |
Total Assets | Not available | $763.61M | $764.99M | $774.33M | $773.93M |
Total Liabilities | Not available | $268.62M | $262.35M | $261.06M | $258.54M |
Cash & Equivalents | Not available | $272.91M | $250.49M | $255.81M | $243.42M |
Free Cash Flow OCF − CapEx | Not available | $-6.25M | $-25.02M | $-20.47M | $-19.21M |
Shares Outstanding | Not available | 50.20M | 49.85M | 50.07M | 50.28M |